Xontogeny

company

Details

Last Funding Type
Series A
Last Funding Money Raised
$15M
Industries
Biopharma,Biotechnology,Health Care,Information Technology
Founded date
Jun 1, 2016
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
Accelerate,MVC

Xontogeny seeks to accelerate the development of life science technologies by providing entrepreneurs with the leadership, strategic guidance and operational support necessary to increase the probability of success in early drug and technology development. Through a differentiated approach, the Xontogeny team partners with the founding scientists and entrepreneurs of new ventures to support their vision while allowing a more efficient development model to benefit company founders and early equity holders.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$15M
Xontogeny has raised a total of $15M in funding over 2 rounds. Their latest funding was raised on May 18, 2017 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 18, 2017 Series A $15M 1 Perceptive Advisors Detail

Investments

Number of Investments
Number of Lead Investments
7
7
Xontogeny has made 7 investments. Their most recent investment was on Dec 13, 2022, when Tellus Therapeutics raised $35M.
Date Company Name
Round Money Raised Industry Lead Investor
Series A $35M Biotechnology Yes
Series A $25M Biopharma Yes
Seed Health Care Yes
Seed Biopharma Yes
Seed Biopharma Yes

Investors

Number of Lead Investors
Number of Investors
1
1
Xontogeny is funded by 1 investors. Perceptive Advisors are the most recent investors.
Investor Name Lead Investor Funding Round
Perceptive Advisors Yes Series A

Employee Profiles

Number of Employee Profiles
4
Xontogeny has 4 current employee profiles, including Executive Chris Garabedian
Executive
Board member
Board member
Executive